I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A PD-L1/EGFR bispecific antibody combines immune checkpoint..:
Laura Rubio-Pérez
;
Rodrigo Lázaro-Gorines
;
Seandean L. Harwood
...
https://www.tandfonline.com/doi/10.1080/2162402X.2023.2205336. , 2023
Link:
https://doi.org/10.1080/2162402X.2023.2205336
RT Journal T1
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:87732fe8a8464638935a3dfe1b8c3ab0&Exemplar=1&LAN=DE A1 Laura Rubio-Pérez A1 Rodrigo Lázaro-Gorines A1 Seandean L. Harwood A1 Marta Compte A1 Rocío Navarro A1 Antonio Tapia-Galisteo A1 Jaume Bonet A1 Belén Blanco A1 Simon Lykkemark A1 Ángel Ramírez-Fernández A1 Mariola Ferreras-Gutiérrez A1 Carmen Domínguez-Alonso A1 Laura Díez-Alonso A1 Alejandro Segura-Tudela A1 Oana Hangiu A1 Ainhoa Erce-Llamazares A1 Francisco J. Blanco A1 Cruz Santos A1 José L. Rodríguez-Peralto A1 Laura Sanz A1 Luis Álvarez-Vallina PB Taylor & Francis Group YR 2023 K1 Cancer immunotherapy K1 bispecific antibody K1 dual action K1 epithelial growth factor receptor K1 immune checkpoint blockade K1 Immunologic diseases. Allergy K1 RC581-607 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.tandfonline.com/doi/10.1080/2162402X.2023.2205336 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2023.2205336 DO https://doi.org/10.1080/2162402X.2023.2205336 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)